Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Early post-ACS bleeding may signal cancer

Key clinical point: Patients with bleeding post-ACS discharge had an elevated risk of a new cancer diagnosis.

Major finding: Patients with bleeding had a hazard ratio of 3.43 for a new cancer diagnosis, with highest risk within the first 6 months after an ACS.

Study details: Retrospective records review of 3,644 patients discharged with dual-antiplatelet therapy after acute coronary syndrome.

Disclosures: The authors reported no outside sources of funding, and no disclosures.

Citation:

Munoz Pousa, I., et al. ESC 2019, Abstract 677.